BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8040976)

  • 1. Potential cost of screening surgeons for HIV.
    Roizen MF; Foss J; Mantha S
    JAMA; 1994 Aug; 272(6):434-5. PubMed ID: 8040976
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
    Levine AA; Sandler RS
    N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of HIV testing of physicians and dentists in the United States.
    Phillips KA; Lowe RA; Kahn JG; Lurie P; Avins AL; Ciccarone D
    JAMA; 1994 Mar; 271(11):851-8. PubMed ID: 8114240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening surgeons for HIV infection: assessment of a potential public health program.
    Schulman KA; McDonald RC; Lynn LA; Frank I; Christakis NA; Schwartz JS
    Infect Control Hosp Epidemiol; 1994 Mar; 15(3):147-55. PubMed ID: 8207171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV screening for healthcare providers: can we provide sense and sensibility without pride or prejudice?
    Henderson DK
    Infect Control Hosp Epidemiol; 1994 Oct; 15(10):631-4. PubMed ID: 7844333
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis of screening health care workers for HIV.
    Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
    J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Think HIV: why physicians should lower their threshold for HIV testing.
    Freedberg KA; Samet JH
    Arch Intern Med; 1999 Sep; 159(17):1994-2000. PubMed ID: 10510984
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening surgeons for HIV infection. A cost-effectiveness analysis.
    Owens DK; Harris RA; Scott PM; Nease RF
    Ann Intern Med; 1995 May; 122(9):641-52. PubMed ID: 7702225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis sparks new debate about current HIV screening recommendations.
    Dis Manag Advis; 2007 Aug; 13(8):95-6, 85. PubMed ID: 17802675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV screening of surgeons and dentists: a cost-effectiveness analysis.
    Sell RL; Jovell AJ; Siegel JE
    Infect Control Hosp Epidemiol; 1994 Oct; 15(10):635-45. PubMed ID: 7844334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to prenatal HIV testing.
    Remis RS; Patrick DM
    CMAJ; 1998 Jun; 158(11):1469-70. PubMed ID: 9629111
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology ... how cost effective would it be to test health care workers for HIV?
    Hosp Health Netw; 1994 May; 68(9):19. PubMed ID: 8167751
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
    Gómez M
    Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of HIV screening of blood transfusions in Zambia.
    Foster S; Buvé A
    Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal HIV screening of pregnant women in England: cost effectiveness analysis.
    Postma MJ; Beck EJ; Mandalia S; Sherr L; Walters MD; Houweling H; Jager JC
    BMJ; 1999 Jun; 318(7199):1656-60. PubMed ID: 10373167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partner notification for HIV control.
    Judson FN
    Hosp Pract (Off Ed); 1990 Dec; 25(12):63-70, 73. PubMed ID: 2123213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal voluntary testing and treatment for prevention of HIV transmission.
    Dieffenbach CW; Fauci AS
    JAMA; 2009 Jun; 301(22):2380-2. PubMed ID: 19509386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.